REQUEST A DEMO
Total
USD $0.00
Search more companies

Pell Bio-Med Technology Co. Ltd. (Taiwan, China)

Main Activities: Research and Development in Nanotechnology
Full name: Pell Bio-Med Technology Co. Ltd. Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Pell Bio-Med Technology Co. Ltd. is a company in Taiwan, China, with a head office in Taipei City. The enterprise operates in the Research and Development in Nanotechnology industry. The company was established on May 22, 2026. The company’s latest financial report indicates a net sales revenue increase of 60.07% in 2025. Over the same period, its total assets grew by 21.06%. In, 2025, the company’s net profit margin increased by 555.86%.

Headquarters
Neihu Dist4F.,No.87,Xinhu 2Nd Rd
Taipei City; Taipei City;

Contact Details: Purchase the Pell Bio-Med Technology Co. Ltd. report to view the information.

Website: http://www.pellbmt.com

Basic Information
Outstanding Shares:
Purchase the Pell Bio-Med Technology Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Pell Bio-Med Technology Co. Ltd. report to view the information.
Incorporation Date:
May 22, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
10.23%
Purchase this report to view the information.
7.12%
Purchase this report to view the information.
4.52%
Purchase this report to view the information.
3.85%
Purchase this report to view the information.
3.61%
Subsidiaries
鉑森生技股份有限公司
100%
台灣細胞製造股份有限公司
66.88%
Company Performance
Financial values in the chart are available after Pell Bio-Med Technology Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
60.07%
Total Operating Revenue
24.18%
Operating Profit
-14.21%
EBITDA
-16.36%
Net Profit/Loss for the Period
-15.87%
Total Assets
21.06%
Total Equity
31.7%
Operating Profit Margin
595.96%
Net Profit Margin
555.86%
Return on Equity (ROE)
3.7%
Debt / Equity
-14.35%
Quick Ratio
0.71%
Cash Ratio
-0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?